Zhitong Finance App News, Shengnuo Biotech (688117.SH) announced that Meishan Huilong Pharmaceutical Technology Co., Ltd. (“Meishan Huilong”), a wholly-owned subsidiary of the company, recently received the “Certificate of Export of APIs from the Sichuan Drug Administration of the People's Republic of China” from the Sichuan Drug Administration to export to the European Union: tirzepatide (Tirzepatide).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.